Albuminuria in the normal range: the lower is not the better.
作者： Carmine Zoccali , Francesca Mallamaci
DOI: 10.1016/J.JACC.2013.01.049
关键词: Intensive care medicine 、 Disease 、 Albuminuria 、 Disease prevention 、 Healthcare system 、 Microalbuminuria 、 Medicine 、 Normal range 、 Cvd risk
摘要: The burden of cardiovascular disease (CVD) is the most complex and resource-demanding problem that health systems face worldwide ([1][1]). Cardiovascular prevention programs have been put in place countries but there a still quest for studies on how to refine CVD risk
onlinejacc.org 参考文章(19)
MR Law, NJ Wald, Risk factor thresholds: their existence under scrutiny BMJ. ,vol. 324, pp. 1570- 1576 ,(2002) , 10.1136/BMJ.324.7353.1570
Csaba P. Kovesdy, Evan H. Lott, Jun Ling Lu, Sandra M. Malakauskas, Jennie Z. Ma, Miklos Z. Molnar, Kamyar Kalantar-Zadeh, Outcomes associated with microalbuminuria: effect modification by chronic kidney disease. Journal of the American College of Cardiology. ,vol. 61, pp. 1626- 1633 ,(2013) , 10.1016/J.JACC.2012.11.071
G F H Diercks, W H van Gilst, J L Rouleau, P E de Jong, A J van Boven, J L Hillege, The importance of microalbuminuria as a cardiovascular risk indicator: A review Canadian Journal of Cardiology. ,vol. 18, pp. 525- 535 ,(2002)
James H. Ware, The limitations of risk factors as prognostic tools. The New England Journal of Medicine. ,vol. 355, pp. 2615- 2617 ,(2006) , 10.1056/NEJMP068249
Charlotte Watts, Sandy Cairncross, Should the GBD risk factor rankings be used to guide policy The Lancet. ,vol. 380, pp. 2060- 2061 ,(2012) , 10.1016/S0140-6736(12)62121-7
Abhijit V. Kshirsagar, Andrew S. Bomback, Heejung Bang, Linda M. Gerber, Suma Vupputuri, David A. Shoham, Madhu Mazumdar, Christie M. Ballantyne, James J. Paparello, Philip J. Klemmer, Association of C-Reactive Protein and Microalbuminuria (from the National Health and Nutrition Examination Surveys, 1999 to 2004) The American Journal of Cardiology. ,vol. 101, pp. 401- 406 ,(2008) , 10.1016/J.AMJCARD.2007.08.041
Klaus Klausen, Knut Borch-Johnsen, Bo Feldt-Rasmussen, Gorm Jensen, Peter Clausen, Henrik Scharling, Merete Appleyard, Jan Skov Jensen, Very Low Levels of Microalbuminuria Are Associated With Increased Risk of Coronary Heart Disease and Death Independently of Renal Function, Hypertension, and Diabetes Circulation. ,vol. 110, pp. 32- 35 ,(2004) , 10.1161/01.CIR.0000133312.96477.48
Paul E. de Jong, Gary C. Curhan, Screening, Monitoring, and Treatment of Albuminuria: Public Health Perspectives Journal of The American Society of Nephrology. ,vol. 17, pp. 2120- 2126 ,(2006) , 10.1681/ASN.2006010097
Johannes FE Mann, Roland E Schmieder, Matthew McQueen, Leanne Dyal, Helmut Schumacher, Janice Pogue, Xingyu Wang, Aldo Maggioni, Andrzej Budaj, Suphachai Chaithiraphan, Kenneth Dickstein, Matyas Keltai, Kaj Metsärinne, Ali Oto, Alexander Parkhomenko, Leopoldo S Piegas, Tage L Svendsen, Koon K Teo, Salim Yusuf, None, Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial The Lancet. ,vol. 372, pp. 547- 553 ,(2008) , 10.1016/S0140-6736(08)61236-2